SecBot SecBot
SECBOTREPLAY Home › Report › SPRO

SPRO · Spero Therapeutics announced it will release its Q4 and full-year 2025…

Spero Therapeutics, Inc. · PRESS-RELEASE filed Mar 18, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 4/10

PRESS-RELEASE filed Mar 18, 2026 at 16:05 ET

Spero Therapeutics announced it will release its Q4 and full-year 2025 financial results on March 26, 2026, after market close. The company will not host a conference call, limiting immediate investor engagement and real-time clarification of results.

  • Spero Therapeutics will report Q4 and full-year 2025 financial results on March 26, 2026, after market close.
  • No conference call is planned, which may limit investor interaction and near-term market reaction.
  • Company remains focused on clinical-stage development for rare and high unmet need diseases.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access